用户名: 密码: 验证码:
南瓜蛋白抗胰腺癌作用及其分子机制初步研究
详细信息    本馆镜像全文|  推荐本文 |  |   获取CNKI官网全文
摘要
南瓜蛋白(Cucurmosin CUR)是本课题组从南瓜的瓜瓤中提取的一种新的Ⅰ型核糖体失活蛋白,前期的研究发现CUR能显著诱导黑色素瘤B16和白血病K562等多种肿瘤细胞凋亡和分化。胰腺癌是一种临床表现隐匿、发展迅速和预后极差的消化道常见恶性肿瘤。本课题从体外检测南瓜蛋白的抗肿瘤活性开始,然后观察其诱导PANC-1细胞凋亡和增加吉西他滨的化疗敏感性作用,并通过小鼠胰腺癌原位移植模型测定CUR的体内抗瘤活性,继而在基因水平初步探讨其诱导凋亡和逆转胰腺癌的多药耐药的分子机制,为CUR潜在的抗胰腺癌临床应用提供理论和实验依据。
     目的
     体内外观察CUR对胰腺癌PANC-1细胞的生长抑制作用,并初步探讨其诱导凋亡和逆转多药耐药的分子机制。
     方法
     1.体外MTT法观察CUR对PANC-1细胞生长抑制情况,制作NOD/SCID小鼠胰腺癌原位移植模型,体内观察CUR对胰腺原位移植瘤的抑瘤率。
     2.电子显微镜、流式细胞仪、ELISA等方法观察CUR作用后PANC-1细胞超微结构的改变以及凋亡发生率的影响。
     3.荧光显微镜观察CUR作用后线粒体膜电位(ΔΨm )的变化,western blot检测CUR作用后细胞caspas-3、caspase-9、bcl-2、bax、smac、survivin蛋白以及细胞浆细胞色素C的变化。
     4.体外MTT法观察CUR联合吉西他滨对PANC-1细胞生长抑制作用,western blot检测CUR作用后P-170、MDRP蛋白表达的变化。
     结果
     1.体外CUR对PANC-1细胞生长的影响,不同剂量CUR (0.3125、0.625、2.5、5.0、10、20、40、80ug/ml)作用于PANC-1细胞24h后,细胞增殖抑制率分别为9.2、14.4、20.2、32.0、36.4、44.1、50.3和58.6%,而作用48h的细胞增殖抑制率分别为25.1、35.6、39.7、46.5、52.9、57.0、64.5和72.6%,作用72h的抑制率则为31.4、51.5、60.1、67.2、75.2、85.7、91.0和93.4%。随着作用时间的延长,其抑制率明显增加, 24,48,72h的半数抑制浓度(IC50)分别为40.24μg/m L、8.24μg/m L和1.17μg/m L,呈现明显的时间依赖性。结果提示,南瓜蛋白在体外能以剂量和时间依赖方式明显地抑制PANC-1细胞生长。
     2.体内观察CUR对小鼠胰腺原位移植瘤的抑瘤率,0.125mg/kg、0.25mg/kg和0.5mg/kg CUR的抑瘤率分别为45.2%、50.0%和59.7%,表明不同浓度的CUR对胰腺原位移植瘤的生长均有抑制作用。
     3. CUR对胰腺癌PANC-1细胞周期和凋亡的影响:①CUR处理后,胰腺癌细胞核变小,皱缩,染色质凝集,出现核碎裂。②0、2.5μg/mL、10μg/mL、40μg/mLCUR作用PNAC-1细胞72h, G0/G1期的比例分别为46.56±5.08、53.33±5.05、67.50±6.50和77.00±6.73%,随着药物浓度增加,G0/G1期比例逐渐升高。40μg/mL南瓜蛋白及等量培养液作用PANC-1细胞24、48和72h,G0/G1期的比例分别为56.60±6.65、67.83±6.76和77.00±6.73%,随着作用时间的延长,G0/G1期比例逐渐升高。表明CUR作用PANC-1细胞后,细胞周期阻滞于GO/GI期。③0、2.5、10、40μg/mL的CUR作用胰腺癌PANC-1 72小时的凋亡率分别为2.50士0.13%、8.30士1.23%、23.40士2.45%和48.50士3.65%(P<0.05),随着药物浓度的升高,PANC-1细胞的凋亡率逐渐增加,呈浓度依赖性。40μg/mLCUR作用24、48和72h,PANC-1细胞凋亡率分别为16.51士2.97、38.51士2.38和48.50士3.65%(P<0.05),随着作用时间延长,PANC-1细胞的凋亡率逐渐增加,呈时间依赖性。结果提示,CUR在体外能以剂量和时间依赖方式诱导PANC-1细胞凋亡。④0、2.5、10、40μg/mL的南瓜蛋白作用胰腺癌PANC-1 72小时的caspase-3活性分别0.009、0.011、0.035和0.065酶活力单位。结果显示,随着CUR浓度提高,caspase-3活性显着增高。
     4.线粒体凋亡通道的分子变化:0、2.5,10和40ug/mLCUR处理PANC-172h后,ΔΨm逐渐下降,细胞色素C释放到细胞浆明显增加,caspase-3和caspase-9的活力逐渐增强,smac、bax蛋白表达逐渐增加,而survivin和bcl-2蛋白表达无明显变化。
     5. CUR的化疗增敏作用,GEM单用时(72h)的IC50=36.76nmol/L ,与CUS合用时的GEM的IC50=12.14nmol/L,CUR逆转多药耐药倍数3.02。western blot检测CUR作用后PANC-1细胞多药耐药P-170蛋白表达逐渐减弱,作用呈剂量依赖性,而MDRP蛋白表达无明显变化。
     结论: CUR具有较强的体内、外抗肿瘤活性;且以剂量和时间依赖方式诱导PANC-1细胞凋亡;其机制可能与CUR通过激活PANC-1细胞促凋亡蛋白bax和smac表达增加,致细胞色素C释放到细胞浆增多,活化caspase-9和caspase-3,通过线粒体内在途径诱导细胞凋亡;CUR增加吉西他滨的化疗敏感性,其可能的机制是CUR下调胰腺癌的多药耐药P-170蛋白的表达。
Cucurmosin(CUR), a new ribosome-inactivating proteins(RIP), exhibites anti-tumor and apoptosis-inducing effects both in vitro and in vivo on the human chronic myeloid leukemia K562 cell line and the murine B16 melanoma cell line. Pancreatic cancer is a devastating disease characterized by a very poor prognosis due to the low rates of early diagnosis and rapid progression, with most patients dying within 12 months after diagnosis. The goal of this study was to examine its anti-pancreatic cancer effects both in vitro and in vivo and explore the underlying molecular mechanisms with the aim of providing theoretical rationale and experimental evidence for its potential clinical application.
     Objective
     To investigate the anti-tumor effect of CUR on human pancreatic cancer PANC-1 cells in vitro and in vivo, and to identify the molecular mechanism of CUR on inducing apoptosis and chemo-sensitization.
     Methods
     1. MTT assay was used to determine the effect of CUR on the growth of PANC-1 cells in vitro, orthotopic transplantation NOD/SCID mouse model of pancreatic cancer was established to observe the anti-tumor effect of CUR in vivo.
     2. Electron microscopy, flow cytometric analysis and enzyme linked immunospecific assay were used to examine the apoptosis-inducing effect of CUR.
     3. Fluorescent staining was used to examine the change of mitochondrial membrane potential, and western blot was used to determine the protein level of caspase-3 , caspase-9, bcl-2 , bax, survivin ,smac and cytoplasmic cytochrome-c in PANC-1 cells after CUR treatment.
     4. MTT assay was used to detecte the cytotoxic effect of the different concentrations of CUS with GEM , and western blot was used to determine the protein level of P-170 and MDRP after CUR and GEM treatment.
     Results
     1. In vitro anti-tumor activity of CUR, PANC-1 cells were treated with 0.3125, 0.625, 2.5, 5.0, 10.0, 20.0, 40.0 and 80μg/mL CUR and cell viability was measured at 24, 48 and 72 hours using MTT assay. The inhibitory rates of the cell growth for 24 hours were 9.2, 14.4, 20.2, 32.0, 36.4, 44.1, 50.3 and 58.6% respectively. When treated for 48 hours , the inhibitory rates were 25.1, 35.6, 39.7, 46.5, 52.9, 57.0, 64.5 and 72.6% respectively. When treated for 72 hours, the inbitory rate was 31.4, 51.5, 60.1, 67.2, 75.2, 85.7, 91.0 and 93.4%.The 50% inhibitory concentrations (IC50) of CUR for 24, 48, and 72h were 40.24μg/mL, 8.24μg/mL and 1.17μg/mL respectively. CUR significantly inhibite the proliferation of PANC-1 cells in dosage- and time-dependent manner in vitro.
     2. In vivo anti-tumor activity of CUR, Orthotopic transplantation NOD/SCID mouse model of pancreatic cancer was established .Treatment with CUR at the dose of 0.125, 0.25 and 0.5mg/mL inhibited the growth of pancreatic cancer PANC-1 xenografs by 45.2%, 50.0% and 59.7% respectively. The anti-tumor results in vivo demonstrate that CUR was remarkably active against PANC-1 xenografs in a dose-dependent manner.
     3. Effects of CUR on cell cycle and apoptosis of human pancreatic cancer PANC-1 cells.①After exposure to 10ug/mL CUR for 24h, most cells presented typical morphologic changes of apoptosis such as chromatin condensation or shrunken or fragmentation nucleus by transmission electron microscopy.②Flow cytometric analysis with PI staining was used to detecet cell cycle changing after CUR intervention. Being exposed to 0, 2.5, 10.0, and 40.0ug/mL of the CUS for 72h, the percentage of G0/G1 phase cells was 46.56±5.08, 53.33±5.05,67.50±6.50 and 77.00±6.73 respectively. Being exposed to 40.0μg/mL of the CUS for 24, 48 and 72 hours, the percentage of G0/G1 phase cells was 56.60±6.65, 67.83±6.76 and 77.00±1.73%respectively, These data show that CUR induces the accumulation of PANC-1 cells in the G0/G1 phase of the cell cycle in a dose-dependent and time-dependent maner.③Flow cytometry combined with annexinv-FITC/PI staining showed that CUR induced apoptosis. When PANC-1 cells were incubated with 0 , 2.5,10,40μg/mL CUR for 72h , the rate of apoptosis were 2.50士0.13, 8.30士1.23, 23.40士2.45 and 48.50士3.65%. Being exposed to 40.0μg/mL of the CUS for 24, 48 and 72h, the rate of apoptosis was 16.51士2.97,38.51士2.38 and 48.50士3.65%. Significiant difference was found among them. Thus these data indicate that CUR induces the apoptosis of PANC-1 cells in a dose-dependent and time-dependent maner.④Enzyme linked immunospecific assay was used to detecet caspase-3 activity after CUR treatment. Being exposed to 0, 2.5, 10.0, and 40.0ug/mL of the CUS for 72h, the caspase-3 activity was 0.009,0.011,0.035 and 0.065 units. So the caspase-3 activity was enhanced by CUR in a dose-dependent maner.
     4 molecular mechanism of CUR inducing apoptosis. Western blot analysis indicate that treatment of PANC-1 cells with CUR.(2.5, 10, 40ug/mL) for 72h results in release of mitochondrial cytochrome C and increase expression of bax, smac, caspase-3 and caspases-9 protin level in dose-dependent maner , but survivin、bcl-2 protein level was not significiant altered by CUR .
     5 The 50% inhibitory concentration (IC50) of GEM decrease from 36.76 nmol/L to 12.14 nmol/Lwhen together with CUS, reversal fold is 3.02. Western blot analysis indicate that treatment of PANC-1cells with CUR(2.5,10,40ug/mL) for 72h results in a decrease of P-170 protein level in dose-dependent maner but MDRP protein level was not significiant altered by CUR .
     Conclusion
     1. CUR has superior anti-tumor efficacy on human pancreatic cancer PANC-1 cells in vitro and in vivo via cell apoptosis and G0/G1 cell cycle arrest. CUR induced the apoptosis of PANC-1 cells via the up-regulation of smac and bax gene, leading to release of mitochondrial cytochrome C and then activation of caspase-9 and caspase-3. Thus CUR induces apoptosis via the intrinsic pathway. CUR has a chemo-sensitization effect with gemcitabine on pancreatic cancer cell line PANC-1, which maybe associated with down-regulation of p-170 protein.
引文
[1] Cardenes HR, Chiorean EG, Dewitt J, et al. Locally advanced pancreatic cancer: current therapeutic approach[J]. The Oncologist, 2006, 11:612–623
    [2] Neoptolemos JP, Cunningham D, Friess H, et al. Adjuvant therapy in pancreatic cancer: historical and current perspectives[J]. Annals of Oncology,2003,14:675–692,
    [3]张群华,倪泉兴.胰腺癌2340例临床病例[J].中华医学杂志,2004,84(3): 214-218.
    [4] Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreaticcancer.A randomized controlled trial[J]. JAMA,2007,297(17):267-279
    [5] Oettle H , Richards D, Ramanathan RK, et al. A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancer[J]. Annals of Oncology, 2005,16:1639–1645,
    [6] Abou-Alfa GK, Letourneau R, Harker G, et al. Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer[J]. J Clin Oncol,2006,24(27):4441-4447.
    [7] Cascinu S, Verdecchia L, Valeri N, et al. New target therapies in advanced pancreatic cancer[J].Annals of Oncology, 2006,17 (Supp5): 148–152,
    [8] Bagga S, Seth D, Janendra K. et al. The cytotoxic activity of ribosome-inactivating protein saporin-6 is attributed to its rRNA N-glycosidase and internucleosomal DNA fragmentation activities[J]. J Bio Chem, 2003,278(7):4813–4820
    [9] Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants[J]. Biochim Biophys Acta, 1993,1154(3):237-282.
    [10] Girbes T, Ferreras J M, Arias F J, et al. Description, distribution, activity and phylogenetic relationship of ribosome-inactivating proteins in plants,fungi and bacteria[J]. Mini Rev Med Chem,2004, 4(5): 461-466.
    [11] Chen M, Ye X, Cai J,et al. Crystallization and preliminary crystallographic study of cucurmosin, a ribosome-inactivating protein from the sarcocarp of Cucurbita moschata[J]. Acta Crystallogr D Biol, 2000; 56(5): 665-666
    [12]谢捷明,俞昌喜,陈明晃,等.南瓜蛋白对B16细胞的诱导分化作用[J].中国药理学通报,2006;22(3):329-332.
    [13]陈明晃,叶晓明.一种核糖体失活蛋白—南瓜蛋白[P].中国,发明专利, 99102290.4, 1999-02-21
    [14]陈明晃,谢捷明,叶晓明,石小莉.南瓜蛋白的抗肿瘤活性及其应用[P].中国,发明专利, 03143382.O, 2003-09-29
    [15]谢捷明,陈明晃,许建华,侯晓敏,俞昌喜,叶晓明.南瓜蛋白在制药中的应用[P](优先权).中国,发明专利, 200410092026.X, 2004-11-5
    [16]孙建成,谢捷明,张昆仲,等.南瓜蛋白与STI571体外联合抗K562细胞的作用[J].福建医科大学学报,2008, 42(1):30-32
    [17]陈明晃,谢捷明,许盈,侯晓敏.南瓜蛋白及其编码基因[P].中国,发明专利, 200710008402.6, 2007-01-10
    [18]詹启敏.分子肿瘤学[M],第一版,北京:人民卫生出版社,2005:403-431
    [19] Nagata S. Apoptosis by death receptor[J]. Cell, 1997;88:355-365
    [20] Budihardjo I, Oliver H, Lutter M, et al. Biochemical pathways of caspase-activation during apoptosis[J]. Cell Dev Biol, 1999;15:269-290
    [21] Ambrosini G, Adida C,Altieri DC,et al. A novel anti-apoptosis gene,expressed in cancer and lymphoma[J]. Nat Med,1997:3(8):917-921
    [22] Witham J, Valenti M R, De-Haven-Brandon,A K. et al. The bcl-2/bcl-XL family inhibitorABT-737 sensitizes ovarian cancer cells to carboplatin[J]. Clin Cancer Res, 2007,13(23):7191-7198
    [22] Karikari C A, Roy I, Tryggestad E, et al. Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein[J]. Mol Cancer Ther, 2007,6(3):957-967
    [23] Connor R, Heenan M, Connolly L,et al.Increased anti-tomour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-postive human lung cancer[J]. Anticancer-Res,2004,24(2A):457-464.
    [24]王羽,杨劲,葛卫红.以膜转运蛋白为靶点的胃癌多药耐药研究进展[J].医药导报,2008,27(4):433-435
    [1]张群华,倪泉兴.胰腺癌2340例临床病例[J].中华医学杂志,2004,84(3): 214-218.
    [2] Higinia R. Cardenes, Elena G. Chiorean, John Dewitt,et al.Locally advanced pancreatic cancer: current therapeutic approach[J]. The Oncologist, 2006; 11:612-623
    [3] Neoptolemos JP,Cunningham D, Friess H, et al. Adjuvant therapy in pancreatic cancer: historical and current perspectives[J]. Annals of Oncology, 2003,14:675–692,
    [4] Cascinu S,Verdecchia L,Valeri N,et al. New target therapies in advanced pancreatic cancer[J]. Annals of Oncology , 2006, 17(Suppl5):148–152,
    [5] Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants[J]. Biochim Biophys Acta, 1993,1154(3-4):237-282.
    [6] Girbes T, Ferreras J M, Arias F J, et al. Description, distribution,activity and phylogenetic relationship of ribosome-inactivating proteins in plants,fungi and bacteria[J]. Mini RevMed Chem, 2004, 4(5): 461-466.
    [7] Parikh BA, Tumer NE. Antiviral activity of ribosome inactivating proteins in medicine[J]. Mini Rev Med Chem,2004,4(5):523-43.
    [8] Chen M, Ye X,Cai J,et al. Crystallization and preliminary crystal-graphic study of cucurmosin, a ribosome-inactivating protein from the sarcocarp of cucurbita moschata[J]. Acta Crystallogr D Biol Crystallogr, 2000, 56(5): 665-666
    [9] Hou X, Meehan EJ, Xie J, et al. Atomic resolution structure of cucurmosin, a novel type 1 ribosome-inactivating protein from the sarcocarp of Cucurbita moschata[J].Struct Biol,2008;164(1):81-87.
    [10]汪猷,金善炜.天花粉蛋白[M],第2版,北京:科学出版社,2000:242-330.
    [11]张丽君、姜惠中.天花粉蛋白的临床应用近况及展望[J].中国中西医结合杂志,1994;14(5):319-320
    [12]孔梅.天花粉蛋白诱导白血病细胞K562凋亡的研究[J].实验生物学报,1998;9(3):233-243
    [13]何贤辉,曾耀英,孙荭,等.天花粉蛋白诱导人类白血病细胞株HL60细胞凋亡的研究[J].中国病理生理杂志,2001;17(3):200-203
    [14]涂水平.天花粉蛋白诱导胃癌细胞MKN-45凋亡的研究[J].癌症,2000;19(12):1105-1108
    [15]徐振武,吴裕,陈陵际,等.天花粉蛋白对荷人结肠癌SW-1116裸鼠的体内实验研究[J].浙江肿瘤,1997;3(2):110-112
    [16] Lin JY,Tserny KY, Chen CC ,et al. Abrin and ricin: new anti-tumour substances[J].Nature,1970;227:292-293
    [17]王玉露.核糖体失活蛋白抗肿瘤作用的研究进展[J].海峡药学2003;15(4):1-4
    [18]孙建成,谢捷明,张昆仲,等.南瓜蛋白与STI571体外联合抗K562细胞的作用[J].福建医科大学学报,2008, 42(1):30-32
    [19]谢捷明,俞昌喜,陈明晃,等.南瓜蛋白对B16细胞的诱导分化作用[J].中国药理学通报,2006;22(3):329-332
    [20] Mohammad RM, Dugan MC, Mohamed AN, et al. Establishment of a human pancreatic tumor xenograft model: potential application for preclinical evaluation of novel therapeutic agents[J]. Pancreas, 1998, 16(1):19-25
    [21] Huang SY, Tien HF, Su FH,et al. Nonirradiated NOD/SCID-human chimeric animal model for primary human multiple myeloma,a potential in vivo culture system[J]. Ame J Patho, 2004;164(2):747-756
    [22] Banerjee S, Zhang YX, Ali S,et al .Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer[J].Cancer Res,2005; 65: (19):9064-9072
    [23] Mohammad RM, Katib AA, Pettit G R, et al. An orthotopic model of human pancreatic cancer in severe combined immunodeficient mice: potential application for preclinical studies [J]. Clinical Cancer Research, 1998;4(4), 887-894
    [24] Hotz H, Reber H, Hotz B, et al. An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer[J].Pancreas, 2004, 26 (4) :892-898.
    [25] Katz M H, Takimoto S, Spivack D, et al. An imageable highly metastatic orthotopic red fluorescent protein model of pancreatic cancer[J].Clin Exp Metastasis,2004,21:7-12
    [1] Chow AW,Murillo G,Yu C,et al. The cell cycle and cancer[J]. Proc Natl Acad Sci USA.1997;94:2776-2778.
    [2] Naravanan S, Surendranth K,Bora N. Ribosome inactivating proteins and apoptosis[J]. FEBS lett,2005;579(6):1324-31
    [3] Poma A, Marcozzi G, Cesare P, et al. Antiprotiferative effect and apoptotic response in vitro of human melanoma cells to liposomes containing the ribosome-inactivating protein luffin[J].Biochim Biophys Acta,1999; 1472(1-2):197-205
    [4] Bergamaschi G, Perfetti V, Tonon L. Saporin,a ribosome-inactivating protein used to prepare immunotoxins,induces cell death via apoptosis[J].Br.J. Haematol,1996;98:789-794
    [5]孙建成,谢捷明,张昆仲,等.南瓜蛋白与STI571体外联合抗K562细胞的作用[J].福建医科大学学报,2008, 42(1):30-32
    [6]熊术道,尹丽慧,李景荣,等.苦瓜蛋白对小鼠移植性肝癌H22肿瘤的抑制作用.中华中医药学刊,2007,5(5):949-951
    [7]詹启敏.分子肿瘤学[M],第一版,北京:人民卫生出版社,2005:403-431
    [8] Pietenpol JA, Stewart ZA. Cell cycle checkpoint signaling:cell cyele arrest versus apoptosis.Toxicology,2002,27(181):475-481
    [9]王敬春苗术黄海涛.流式细胞仪在细胞凋亡检测中的应用.齐齐哈尔医学院学报,2007,28(8):970-971
    [10]张志斌,付晓光.紫杉醇对人胰腺癌细胞株BxPC一3增殖抑制作用的研究.中华肿瘤防治杂志,2007, 14(22):1694-1697
    [11]赵蓉,谢捷明,许建华,等.八棱丝瓜蛋白诱导K562细胞凋亡的研究[J].中药药理与临床,2001,17(6):24-26.
    [12]谢捷明,俞昌喜,陈明晃,等.南瓜蛋白对B16细胞的诱导分化作用[J].中国药理学通报,2006;22(3):329-332.
    [13]谢捷明,许盈,陈明晃,等.八棱丝瓜蛋白2对B16细胞的诱导分化作用.福建医科大学学报,2005,39(4):349-352
    [14] Zwall RFA, Schroit AJ. Pathophysiologic implication of membrane phospholipids asymmetry in blood cell[J]. Blood,1997,89:1121-1132
    [15] Tait JF . Clinical application of annexin. annexins: molecular structure to celluar function[J].New York:RG Landes,1996,213-220
    [16] Pigauh C,Follenius-Wund A,Chabbert M. Role of trp-187 in the annexinV-membrane.interaction: A moleeular meehanics analysis[J]. Bioehem BioPhys Res Commun,1999,254:484-489.
    [1]詹启敏.分子肿瘤学[M],第一版,北京:人民卫生出版社,2005:403-431
    [2] Nagata S. Apoptosis b y death receptor [J]. Cell, 1997;88:355-365
    [3] Budihardjo I, Oliver H,Lutter M, et al. Biochemical pathways of caspase activation during apoptosis[J].Cell Dev Biol,1999;15:269-290
    [4] Ambrosini G, Adida C,Altieri DC,et al. A novel anti-apoptosis gene,expressed in cancer and lymphoma[J].Nat Med,1997:3(8):917-921
    [5] Verdecia MA,Huang H, Dutil E,et al. Structure of the human anti-apoptosis protein suvrivin reveals a dimeric arrangment[J]. Nat Struc Biol,2000;7(7):602-608
    [6] Mandal M, Adam L,Mendelsohn J, et al. Nuclear targeting of bax during apoptosis in human colorectal cancer cells[J]. Oncogene,1998,17:999-1007.
    [7] Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c dependent caspase activations by eliminating IAP inhibition[J].Cell,2000,102(1):33-42.
    [8] Wang Z, Tang X, Li Y, et al. 20-Hydroxyeicosatetraenoic acid I nhibits the apoptotic responses in pulmonary artery smooth muscle cells[J]. Eur J Pharma- col,2008,588(1):9-17.
    [9] Bossy-Wetzel E, Newmeyer DD,Green DR. Mitochondrial cytochrome C release in apoptosis occurs upstream of DEVD-specific caspase activation and independently of mitochondrial transmembrane depolarization[J]. EMBO J,1998;17:37-39
    [10] Griffiths GD, Leek MD,Gee DJ. The toxic plant proteins ricin and abrin induce apoptotic changes in mammalian lymphoid tissues andintestine[J].J Pathol,1987,151(3):221-229.
    [11] Bolognesi A, Tazzari P L,Olivieri F, et al.Induction of apoptosis by ribosome 2 inactivating proteins and related immunotoxins[J].In t J Cancer,1996,68(3):349 -355.
    [12] Bergamaschi G, Perfetti V,Tonon L,et al .Saporin,a ribosome-2 inactivating protein used to prepare immunotoxins,induces cell death via apoptosis[J]. Br J Haemato,1996,93(4):789-94.
    [13]孔梅,柯一保,周美云,等.天花粉蛋白诱发白血病细胞K562凋亡的研究[J].实验生物学报,1998,31(3):233-238.
    [14] Poma A,Marcozzi G,Cesare P, et al. Anti-proliferative effect and apoptotic response in vitro of human melanoma cells to liposomes containing the ribosome-2 inactivating protein luffin[J].Biochim B iophyActa,1999, 1472(122):197-205.
    [15]赵蓉,谢捷明,许建华,等.八棱丝瓜蛋白诱导K562细胞凋亡的研究[J].中药药理与临床,2001,17(6):24-26.
    [16] Poma A, M iranda M, Spano L.Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-2 inactivating protein luffin[J]. Melanoma Res,1998,8(5):465-7.
    [17] Chiu L C, Ooi V E, Sun S S. Induction of apoptosis by ribosome-inactivating protein from Agrostemma githago is associated with down-regulation of anti- apopotic bcl-2 protein expression[J]. Int J Oncol,2002,19:137-41.
    [18] Li P, Nijhawan D, Budihardjo I,et al. Cytochrome c and dATP-dependentformation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade [J]. Cell,1997;91(4):479-489
    [19] Zhang XD,Gillespie SK,Hersey R. Staurosporine induces apoptosis of melanoma by both caspase-dependent and-independent apoptotic pathways[J]. Mol Cancer Ther,2004:3(2):187-197.
    [19] Cory S,Adams JM. Killing cancer cells by fipping the bcl-2/bax switch[J].Cancer Cell,2005,8(1):5-6
    [20] Narita M,Shimizu S,Ito T,Chittenden T,et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome C release in isolated mitoehondria[J]. Proc Natl Acad Sci USA.1998,95 (25):14681-14686.
    [21] Tsujimoto Y. Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 2000,7:1174-1181
    [22] Du C,Fang M,Li Y,et al. Smac, a mitochondrial protein that promote cytochrome-c dependent caspase activation by eliminating IAP inhibition. Cell, 2000;102:33-42
    [23] Verhagen AM, Ekert PG, Pakusch M,et al.Identification of DIABLO,a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.Cell,2000;102:43-53.
    [24]李洪波,王道荣. Smac基因调控肿瘤化疗敏感性的研究进展.中国现代普通外科进展, 2007;10(3): 240-243.
    [25] Fulda S,Wick W,Weller M,et al.Smac agonists sensitize for Apo-2L/TRAIL oranticancer drug-induced apoptosis and induce regression of malignant glioma in vivo[J].Nat Med,2002,8(8):808-815.
    [26] Tamm I,Wang Y,Sausville E,et al. IAP-family protein suvrivin inhibits caspase activity and apoptosis induced by Fas(CD95),Bax,and anti- cancer durgs. Caneer Res,1998,58(23):5315-5320
    [27] Mesri M,Wall NR,LI J,et al.Caneer gene therapy using a suvrivin mutant adenoviurs.J Clin Invest,2001:108(7):981-990
    [1] Chou T C, Talalay P. Quantitative analysis of dose-effect relat-ionship : the combined effects of multiple drugs on enzyme inhibitions [J]. Adv Enzyme Regul, 1984, 22(1): 37-41.
    [2] Biedler JL,Riehm H. Celular resistance to actinomycin in Chinese hamster cells in vitro: cross-resistance,radioautographic, and cytogenetic studies [J]. Cancer Res,1970,30;(4):1174-1184.
    [3] Juliano R L,ling V. A surface glycoprotein modulating drug perm-eability in Chinese hamster ovary cell mutans[Jl. Biochem BiophActa,1976,455(1): 152-162.
    [4] Cole SP , Bhardwaj G, Gerlach J H , et al . Overexpression of a trans-porter gene in a multidrug-resistant human lung cancer cell line[J] .Science, 1992 , 258(5088):1650-1654.
    [5] Zhao Lu,Jorg Kleef , Shailesh Shrikhande, et al. Expression of the multi drug resistance -1 (MDR-1) gene and prognosis in human pancreatic cancer[J].Pancreas,2000;21(3):240-247
    [6] Suwa H ,Ohshio G, Aiao S, et al.Immunohistochemical localization of glycoprotein and expression of the muliti drug resistance-1 gene in human panereatic caneer : relevance to indicatior of better prognosis[J]. Jpn J Cancer Res.1996;87:641一649
    [7]彭靖,张玉胜.胰腺癌及其多药耐药的研究[J].医学综述,2008,14(5):677 -680
    [8]廖绍兰,王平.肿瘤的多药耐药机制及逆转剂的研究进展[J].国外医药抗生素分册,2008,29(1):7-12
    [9]龚玉萍,贾永前,刘霆等.环胞霉素A和Genistein逆转MRP多药耐药的研究[J].癌症,2002;21(4):436-437.
    [10] Dan Peer,Yaron Dekel,Dina Melikhov.et al .Fluoxetine inhibits multi-drug resistance extrusion pumps and enhances responses to chemotherapy insyngeneic and in human xenograft mouse tumor models[J].Cancer Res, 2004;64(7):7562–7569.
    [11]李永生,张炎,杨罗艳.粉防己碱逆转P-gp介导的膀胱肿瘤多药耐药的实验研究[J].中国现代医学杂志,2003;13(20):82-90.
    [12] Connor R, Heenan M, Connolly L,et al.Increased anti-tomour efficacy of doxorubicin when combined with sulindac in a xenograft model of an MRP-1-postive human lung cancer[J]. Anticancer-Res,2004;24(2A):457-464.
    [1]. Yeung HW, Li WW, Feng Z. Trichosanthin, Alphamomorcharinand beta-momorcharin: - identity of abortifacient and ribosome-inactivating proteins[J]. Int.J.Pept. Protein Res, 1988;31:265-268
    [2]. Zarling JM, Moran PA, Haffar O. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies[J]. Nature,1990;347:92-95
    [3]. Stirpe F, Barbieri L, Battelli MG. Ribosome-inactivating proteins from plants: present status and future prospects[J].Biotecnology, 1992;10(4):405-12
    [4]. Liu.RS,Yang JH. Liu WY. lsoltaion and enzymatic chracteristicn of lamjapin,the first ribosome inactivating protein from cryptogamic algal plant [J].EuorJ Biochem,2002;269:4746~4752s
    [5]. Lam SK, Ng TB. First simultaneous isolation of ribosome inactivating protein and antifunga1 protein and antifunga1 protein from a mushroom together with evidence for synergism of their antifungal effects[J]. Arch Biochem Biophys .2001;393:271~280
    [6].Monzingo AF,collins EJ. The structure of pokeweed antiviral protein. J Mo1 Bio,1993;233:705~15
    [7].詹金彪.植物蛋白毒性和抗肿瘤活性[J].浙江医科大学学报,1992,21 (1):41-43
    [8].詹金彪.植物核糖体失活蛋白和在肿瘤治疗中的应用[J].浙江医科大学学报,1991,20(5):233-236.
    [9]. Lin JY, Tserny KY, Chen CC, et al. Abrin and ricin: new anti-tumour substances[J].Nature,1970;227:292-93
    [10].李霖,王文学,邹伯英.蓖麻毒素修饰物的制备和细胞毒作用[J].第四军医大学学报,1996;17(3):178-180
    [11].Bolognesi A,Tazzari PL,Olivieri F,et al.Evaluation of immunotoxins containing single-chain ribosome-inactivating proteins and anti-CD22 monoclonal antibody(OM124):in vitro and in vivo studies. Br J Haematol,1998;101:179-188
    [12].Frankel A E ,Nevilla D M, Bugge TA, et al. Immunotoxin therapy of hematologic malignancies[J]. Semin Oncol,2003,30(4):545-557.
    [13]. Rustamzadeh E, Low W C,Vellera D A, et al. Immunotoxin therapy for CNS tumor[J]. Neurooncol,2003,64(1-2):101-116.
    [14].Griffiths GD, Leek MD, Gee DJ. The toxic plant proteins ricin and abrin induce apoptotic changes in mamanalian lymphoid tissues and intestine[J] .Pathol. 1987;151:221-229
    [15]. Kong M,Ke YB, Zhou MY. Study on trichosanthin induced apoptosis of leukemia K562 cells[J]. Shi Yan Shang Wu Xue Bao, 1998:31(3):233-43
    [16].Naravanan S, Surendranth K,Bora N. Ribosome inactivating proteins and apoptosis[J]. FEBS Lett,2005;579(6):1324-31
    [17].Poma A, Marcozzi G, Cesare P, et al. Antiprotiferative effect and apoptotic response in vitro of human melanoma cells to liposomes containing the ribosome-inactivating protein luffin[J].Biochim Biophys Acta,1999;1472(1-2):197- 205
    [18].Bergamaschi G, Perfetti V, Tonon L. Saporin,a ribosome-inactivating protein used to prepare immunotoxins, induces cell death via apoptosis[J]. Br.J. Haematol,1996;98:789-794
    [19].张丽君、姜惠中.天花粉蛋白的临床应用近况及展望[J].中国中西医结合杂志,1994;14(5):319-320
    [20].孔梅,等.天花粉蛋白诱导白血病细胞K562凋亡的研究[J].实验生物学报,1998;9(3):233-243
    [21].何贤辉,曾耀英,孙荭,等.天花粉蛋白诱导人类白血病细胞株HL60细胞凋亡的研究[J].中国病理生理杂志,2001;17(3):200-203
    [22].涂水平.天花粉蛋白诱导胃癌细胞MKN-45凋亡的研究[J].癌症,2000;19(12):1105-08
    [23].徐振武,吴裕,陈陵际,等.天花粉蛋白对荷人结肠癌SW-1116裸鼠的体内实验研究[J].浙江肿瘤,1997;3(2):110
    [24].Lin JY, Tserny KY, Chen CC, et al. Abrin and ricin: new anti-tumour substances[J].Nature,1970;227:292-93
    [25].王玉露.核糖体失活蛋白抗肿瘤作用的研究进展.海峡药学,2003;15(4):1-4
    [26]. Lin J, Yang F, Tang L, et al. Anti-tumor effects of curcin from seeds of Jatropha curcas[J]. Acta Pharmacol Sin,2003;24(3):241-46
    [27]. Lee-Huang S, Huang PL, Sun Y, et al. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by antitumor agents and MAP30[J].Antcancer Res,2000;20:653-659
    [28]. Ling J, Liu WY. Cytotoxicity of two new ribosome-inactivating proteins, cinnamomin and camphorin to carcinoma cells[J]. Cell Biochem Funct,1996;14(3): 157–61
    [29].Irvin J D, Uckun FM. Pokeweed antiviral protein:ribosome inactivation and therapeutic applications[J].Pharmacol Ther,1992;55(3):279-302
    [30].Siegall CB, Gawlak SL ,Chace D, et al. Characterization of ribosome inactiveating proteins isolated from Bryonia dioica and their utility as carcinoma reactive immuno-conjugates[J]. Bioconjug chem,1994;5(5):423-9
    [31].Bolognesi A, Tazzari PL, Olivieri F. Induction of apoptosis byribosome- inactivating proteins and related immnnotoxins[J]. Int J Cancer,1996;68(3):349-55
    [32].鲁继彬,李厚文,王明武,等.免疫毒素CMU15A-TCS对人肺腺癌超级结构的影响[J]. China J Phy Med,1997;19(1):50-51
    [33].Hirota N,Ueda M, Ozawa S,et al. Suppression of an epidermal growth factorreceptor-hyperproducing tumor by and immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody[J]. Cancer Res,1989;9(24 Pt1):7106-9
    [34]. Qi L, Nett TM, Allen MC, et al. GnRH-PAP hormonotoxin targets cytotoxicity to prostate cancer cell lines[J]. Urol Res,2003;31(6):374-7
    [35].Schlich J,Dulieu P,Desvoyes B,et al. Cytotoxic activating of a recombinant GnRH-PAP from toxin on human tumor cell lines[J].FEBS Lett,2000;472(2-3):241- 6
    [36]. French RR,Bell AJ, Hambin TJ, et al. Response of B-cell lymphoma to a combination of bispecific antibodies and saporin[J]. Leuk Res,1996;20(7):607-71
    [37]. Munoz R,Arias Y,Ferreras JM,et al.Sensitivity of cancer cell lines to thenovel non-toxic type 2 ribosome-inactivating protein nigrin [J].Cancer Lett, 2001;167(2):163-9
    [38]. Lambert JM, Blattler WA, Mcintyre GD,et al. Immuonotoxins containing single-chain ribosome-inactivating proteins[J]. Canaer Treat Res,1988;60(37): 175-209
    [39]. Chan WL,Zheng YT,Huang H, et al .Relationship between trichosanthin cytotoxicity and its intracellular concentration[J]. Toxicology,2002;177(2-3):245–51
    [40].谢捷明,许建华,陈明晃,等.南瓜蛋白对B16细胞的诱导分化作用[J].福建医科大学学报,2004;38(4):394-8
    [41].谢捷明,俞昌喜,陈明晃,等.南瓜蛋白对B16细胞的诱导分化作用[J].中国药理学通报,2006;22(3):329-332
    [42].Chiu LC,Ooi VE,Sun SS.Induction of apoptosis by a ribosome-inactivating protein from agrostemma githago is associated with down-regulation of anti-apoptotic bcl-2 protein expression[J].Int J Oncol,2001;19(1):137-41
    [43].Zhang C, Gong Y,Ma H, et al. Reactive oxygen species involved in trichosanthin-induced apoptosis of human choriocarcinoma cells[J].Biochem J 2001;355(3):653-661
    [44].Ling J, Liu WY. Cytotoxicity of two new ribosome-inactivating protein, cinnamomin and camphorin to carcinoma cells[J]. Cell Biochem Function.1996; 14(3):157-161
    [45]. Poma A,Zarivi O, Bianchini S, et al.The plant ribosome inactivating protein saporin induces micronucleus formation in peripheral human lymphocytes in vitro. Toxicol Lett 1999;105(1):67-73
    [46]. Poma A,Miranda M,Spano L. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin[J]. Melanoma Res 1998;8(5):465-467
    [47].郎海滨,糜漫天,程天民,等.苦瓜核糖体失活蛋白的纯化及其诱导HL-60细胞凋亡的研究[J].营养学报,2004;26(2):139-142
    [48].郎海滨,糜漫天,程天民等,苦瓜核糖体失活蛋白诱导HL-60细胞凋亡及其分子机制的研究[J].第三军医大学学报,2003;25(13):1157-60
    [49]. Hu R, Zhai Q, Liu W, et al. An insight into the mechanism of cytotoxicity of ricin to hepatoma cell: roles of Bcl-2 family proteins,caspases,ca2+-dependent proteases and protein kinase C[J]. J Cell Biochem,2001;81(4):583-93
    [50]. Mi SL,An CC,Wang Y, et al. Trichomislin, a novel ribosome-inactivating protein,induces apoptosis that involves mitochondria and caspase-3[J].Arch Biochem Biophys,2005;434(2):258-65
    [51].Bussing A,Vervecken W,Wagner M, et al. Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizingviscotoxins[J]. Cytometry 1999;37(2):133-139
    [52].Sriram N,Avadhesha S,Anjali AK .Riosome-inactivating protein and apoptosis;abrin causes cell death via mitochondrial pathway in Jurkat cells[J]. Biochem J,2004;377:233-40

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700